ARCHIVES

Xgeva Delays Metastases To Bone, Amgen Files To Expand Indication

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Illinois Comprehensive Center Core Grant Approved, Probably Will Be Funded in FY 79

September 29, 1978

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

March 10, 1989

Senate Committee Approves $27 Billion for NIH, $4.6 Billion for NCI

August 2, 2002

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

ACS Funds Pilot Study Of Mammography Trial

July 28, 1995

Funding Opportunity: DOD Offering 10.5 Million For Lung Cancer Research

May 30, 2014